Clinical trial

Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients

NCT01291459

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention MVC/RAL/FTC/TDF followed by Maraviroc/Raltegravir Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2011-09-01

PhasePHASE2

Conditions

HIVunresolved

Interventions

MVC/RAL/FTC/TDF followed by Maraviroc/RaltegravirDRUG

Sponsors & collaborators

Association Pour la Recherche en Infectiologielead sponsor

Mapped research locations

ParisFrance2 MarseilleFrance2 LyonFrance2 NantesFrance1 NiceFrance1 Clermont-FerrandFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01291459 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.